H E Frech
Biographic Data
| ID | 1242166 |
|---|---|
| NAME | H E Frech |
| GIVEN NAMES | H E |
| FAMILY NAME | Frech |
| SIGNATURE | FRECH H E |
| AFFILIATIONS | University of California, Santa Barbara |
| VERIFIED | No |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 31 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1973 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 3 |
Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the 1994–2015 Tufts Registry of Cost-Effectiveness Analyses. Earlier studies used small, specialized samples of drugs. We use linear regression analysis to estimate t…
Health Economics Worldwide
Health Care in America: The Political Economy of Hospitals and Health Insurance
Health Care in America: The Political Economy of Hospitals and Health Insurance
The Health Economy . Victor R. Fuchs
The effect of the California Coastal Commission on housing prices
The Property Rights Theory of the Firm: Empirical Results from a Natural Experiment
Property Rights and the Dynamic Inefficiency of Capitalism: Comment
The public choice theory of murray N. Rothbard, a modern anarchist
The Property Rights Theory of the Firm: Empirical Results from a Natural Experiment
The effect of the California Coastal Commission on housing prices
The public choice theory of murray N. Rothbard, a modern anarchist
Property Rights and the Dynamic Inefficiency of Capitalism: Comment
Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the 1994–2015 Tufts Registry of Cost-Effectiveness Analyses. Earlier studies used small, specialized samples of drugs. We use linear regression analysis to estimate t…
The public choice theory of murray N. Rothbard, a modern anarchist
Property Rights and the Dynamic Inefficiency of Capitalism: Comment
The Property Rights Theory of the Firm: Empirical Results from a Natural Experiment
The effect of the California Coastal Commission on housing prices
The Health Economy . Victor R. Fuchs
Health Care in America: The Political Economy of Hospitals and Health Insurance
Health Care in America: The Political Economy of Hospitals and Health Insurance
Health Economics Worldwide
Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the 1994–2015 Tufts Registry of Cost-Effectiveness Analyses. Earlier studies used small, specialized samples of drugs. We use linear regression analysis to estimate t…
Economics (9 works) · Political science (5 works) · Health care (4 works) · Law (4 works) · Law (4 works) · Politics (4 works) · Business (3 works) · Economic growth (3 works) · Econometrics (2 works) · Economic Theory and Institutions (2 works)